跳转至内容
Merck
CN

595187

~40 wt % dispersion in mineral oil

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
Li
化学文摘社编号:
分子量:
6.94
EC Number:
231-102-5
UNSPSC Code:
12352000
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

WHXSMMKQMYFTQS-UHFFFAOYSA-N

InChI

1S/Li

SMILES string

[Li]

reaction suitability

reagent type: reductant

concentration

~40 wt % dispersion in mineral oil

resistivity

9.446 μΩ-cm, 20°C

bp

1342 °C (lit.)

mp

180 °C (lit.)

density

0.534 g/mL at 25 °C (lit.)

正在寻找类似产品? 访问 产品对比指南

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

U Eismann et al.
Optics express, 21(7), 9091-9102 (2013-04-11)
We present an all-solid-state laser source emitting up to 2.1 W of single-frequency light at 671 nm developed for laser cooling of lithium atoms. It is based on a diode-pumped, neodymium-doped orthovanadate (Nd:YVO(4)) ring laser operating at 1342 nm. Optimization
M Sathiya et al.
Nature materials, 12(9), 827-835 (2013-07-16)
Li-ion batteries have contributed to the commercial success of portable electronics and may soon dominate the electric transportation market provided that major scientific advances including new materials and concepts are developed. Classical positive electrodes for Li-ion technology operate mainly through
Rebecca F McKnight et al.
Lancet (London, England), 379(9817), 721-728 (2012-01-24)
Lithium is a widely used and effective treatment for mood disorders. There has been concern about its safety but no adequate synthesis of the evidence for adverse effects. We aimed to undertake a clinically informative, systematic toxicity profile of lithium.
Annemiek Dols et al.
International clinical psychopharmacology, 28(6), 287-296 (2013-07-23)
Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects
Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持